SUFENTANYL
Post Operative Pain
Hospital Central do FunchalSmall moleculePhase 4 / ApprovedDormant
BB
68/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 53/ 100
- Competitive Position
- 95/ 100
Competitive context
13 Active assets in the Post Operative Pain cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE Assiut University | Phase 4 | BB |
NEPENTHE Ondokuz Mayıs University | Phase 4 | BB |
LIDOCAINE The University of Texas Health Science Center, Houston | Phase 4 | BB |
METHADONE The Cleveland Clinic | Phase 4 | BB |
Pregabalin Nova Scotia Health Authority | Phase 3 | B |
View all 17 →
Same molecule, other indications
SUFENTANYL is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →